Log in

ADVIKLA MPS PHARMAA LIMITED BSE · India

MPS PHARMAA LIMITED (ADVIKLA) news

MPS PHARMAA LIMITED is a public biotech or pharmaceutical company listed on BSE under the ticker ADVIKLA, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest MPS PHARMAA LIMITED news

We have not published a story on MPS PHARMAA LIMITED yet. When there is news, it will appear here.

Questions about MPS PHARMAA LIMITED

What is the ticker symbol of MPS PHARMAA LIMITED?

MPS PHARMAA LIMITED trades under the ticker ADVIKLA on BSE.

Where is MPS PHARMAA LIMITED listed?

MPS PHARMAA LIMITED is listed on BSE.

Which country or territory is MPS PHARMAA LIMITED listed under?

Our directory records MPS PHARMAA LIMITED under India.

What does MPS PHARMAA LIMITED do?

Our directory classifies MPS PHARMAA LIMITED as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of MPS PHARMAA LIMITED?

The ISIN recorded for MPS PHARMAA LIMITED is INE537C01019.

Does aibio.space cover MPS PHARMAA LIMITED?

aibio.space lists MPS PHARMAA LIMITED among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to MPS PHARMAA LIMITED?

Companies in our directory listed in the same country and business area as MPS PHARMAA LIMITED: SMS Pharmaceuticals, Windlas Biotech, Accretion Pharmaceuticals, Mankind Pharma, JFL Life Sciences, Emcure Pharmaceuticals.

Investor discussion: MPS PHARMAA LIMITED

Members talk about MPS PHARMAA LIMITED (ADVIKLA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open BSE:ADVIKLA on TradingView.

Listing details

MPS PHARMAA LIMITED is a public biotech or pharmaceutical company listed on BSE under the ticker ADVIKLA, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
MPS PHARMAA LIMITED
Ticker
ADVIKLA
Listing
BSE
Country or territory
India
Business scope
Pharmaceuticals: Major
ISIN
INE537C01019
Last quote in directory
2026-10-19
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.